A confirmation of chronic graft- versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation

Haematologica. 2019 Jul;104(7):e314-e317. doi: 10.3324/haematol.2018.199646. Epub 2019 Jan 17.

¹ Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
² Division of Hematology, Saitama Medical Center, Jichi Medicial University, Saitama, Japan.
³ Division of Hematological Malignancies, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ The Emmes Corporation, Rockville, MD, USA.
⁵ Division of Pediatrics BMT, Minneapolis, MN, USA.
⁶ Center for International Blood and Marrow Transplant Research, Minneapolis Campus, Minneapolis, MN, USA.
⁷ Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA dmiklos@stanford.edu.

No abstract available

Publication types